baber/WOPTO huggingface dataset:
Patent CS-211387-B2 (CS)
Title: Single-stage reverse pumping turbine
Inventor: VRCAR ANTON
IPC: F03B13/06
Filed: 1978-02-21
Abstract: In a hydroelectric facility, a vertically mounted rotatable shaft is connected to a motor-generator and carries a pump-turbine with a supplying pump disposed below and immersed in water, the supplying pump disengaging from the shaft when the pump-turbine is driving the motor-generator and engaging the shaft when the motor-generator is driving the pump-turbine and supplying pump, thereby providing a two-stage pumping mode and a single-stage generating mode.
Patent CS-226444-B2 (CS)
Title: Method of preparing 2,3-dichloro-5-trichloromethylpyridine
Inventor: WERNER JOHN A
IPC: C07B61/00
Filed: 1982-03-12
Abstract: Preparation of 2,3-dichloro-5-trichloromethylpyridine in high yields and purity by chlorinating 2-chloro-5-trichloro- methylpyridine at 70 to 250 °C with chlorine in the presence of a catalyst containing one or more molybdenum, tungsten or ruthenium compounds.
Patent CS-221260-B2 (CS)
Title: Facility for introducing at least one yearn in the injection nozzle of pneumatic shaping device
Inventor: BIOT BERNARD
IPC: D02J1/00
Filed: 1976-06-02
Abstract: A yarn is fed into the feed duct of a pneumatic texturing device by threading the yarn across the entry of the feed duct transversely to the axis of the feed duct. The yarn is cut with a cutter downstream of the entry and operation of the cutter in synchronized with the prodn. of a pressure fluid jet from a nozzle. The fluid jet forms a loop of yarn which moves into the entry from which it passes into the feed duct. Threading can be automatically effected at high speeds, e.g. with the yarn moving across the entry at speeds greater than 2000 metres/min.
Patent CS-235331-B2 (CS)
Title: Method of cephoperazone's crystalline salt production
Inventor: NAKANISHI SUSUMU
IPC: A61K31/395
Filed: 1983-07-19
Abstract: Crystalline sodium cefoperazone and a process for its manufacture in a form essentially free of residual organic solvents which comprises the steps of combining an aqueous acetone solution containing from about 3 to 30 percent (w/v) of sodium cefoperazone with about a four-fold volume (v/v) of a solution of acetone-methylene chloride (95:5, v/v) at a temperature of about 5-40°C.; and separating and drying the resulting crystalline sodium cefoperazone.
Patent CS-219342-B2 (CS)
Title: Method of preparation of the glycoside of the pleuromutiline
Inventor: NAGARAJAN RAMAKRISHNAN
IPC: A61P31/04
Filed: 1978-12-04
Abstract: Novel pleuromutilin gylcoside derivatives are useful agents with activity against gram-positive and gram-negative bacteria anaerobes and mycoplasma.
Patent CS-207695-B2 (CS)
Title: Fodder mixture
Inventor: HILLER GUENTER
IPC: A23K1/165
Filed: 1978-12-08
Abstract: Animal feeds based on carbohydrates, protein and fats containing from 5 to 350 ppm of one of the growth promoters Nitrovin, Carbadox or Olaquindox and a content of proteolytic enzymes in such an amount that the enzymatic activity is from 0.05 to 2.5 mTU/gm of said animal feed.
Patent AU-605235-B2 (AU)
Title: Alkylmelatonins
Inventor: FLAUGH MICHAEL EDWARD
IPC: C07D405/06
Filed: 1988-01-29
Granted: 1991-01-10
Abstract: beta -Alkylmelatonins are useful as ovulation inhibitors.
Patent AU-652807-B2 (AU)
Title: High dynamic range closed loop automatic gain control circuit
Inventor: WHEATLEY CHARLES E III
IPC: H03G3/30
Filed: 1991-11-27
Granted: 1994-09-08
Abstract: A closed loop automatic gain control (AGC) circuit with high dynamic range capabilities having an amplifier circuit for receiving an input signal, which is susceptible to variations in signal power, and a control signal. The amplifier circuit is responsive to the control signal for amplifying the input signal at a gain level corresponding to the control signal so as to provide a corresponding output signal. A measurement circuit is coupled to the amplifier means for measuring logarithmic signal power of the amplified input signal and providing a corresponding linear measurement signal. An integration circuit is included for receiving the measurement signal, and a reference signal which corresponds to a desired signal power of the output signal. The integration circuit integrates with respect to time the difference between the measurement signal and the reference signal, and generates the control signal which corresponds to the result of the integration.
Patent AU-685560-B2 (AU)
Title: Antiviral composition of viral protein trans-dominant variants
Inventor: MEHTALI MAJID
IPC: C07K14/16
Filed: 1994-12-13
Granted: 1998-01-22
Abstract: A composition resulting from a combination of trans-dominant variants of two viral proteins from a single virus, and the use thereof as a combination product are disclosed. A vector for expressing the two variants, a eukaryotic cell containing same, and a pharmaceutical composition for treating viral infections, are also disclosed.
Patent AU-782666-B2 (AU)
Title: Method for producing a bank or collection of mutants and applications thereof
Inventor: TISSIER ALAIN
IPC: A01H1/06
Filed: 2000-10-27
Granted: 2005-08-18
Abstract: The invention concerns a method for producing a bank or collection of mutants enabling the study of the function of each gene, DNA fragment or specific sequence of a given plant species and its applications: banks of mutants and selection of a gene mutant.
Patent AU-697168-B2 (AU)
Title: Sterile occlusion fasteners and instrument and method for their placement
Inventor: FOGELBERG MARK
IPC: A61B17/128
Filed: 1995-03-01
Granted: 1998-10-01
Abstract: A clip, clip applier and method for ligating a tissue structure is provided. The applier has a two stage actuation. In the first stage, a tissue structure is positioned into the jaws of the clip applier The jaws close and lock to a preset force to compress and temporarily occlude the tissue structure. If satisfactorily positioned, the second stage is initiated in which a clip is advanced through the shaft of the clip applier in a closed position. At the distal end of the clip applier, the clip is opened slightly to capture the pre-compressed tissue structure, and is placed over the structure. The clip is then dissociated from the business end of the instrument. Preferably the clip comprises two leg members disposed in close proximity to one another joined from opposing directions by a connecting element. The connecting element restricts separation of the leg members with opposing spring members so as to provide substantially uniform parallel deflection of the leg members from each other. <IMAGE>
Patent AU-771408-B2 (AU)
Title: Intramedullary nail
Inventor: FRIGG ROBERT
IPC: A61B17/78
Filed: 1999-12-03
Granted: 2004-03-18
Abstract: The invention relates to an intramedullary nail used for treating fractures of the femur. It comprises a distal end, which is appointed for insertion into the marrow cavity channel, a proximal end, and a longitudinal axis. A first bore is located adjacent the proximal end and extends through the proximal end and transversely intersects the longitudinal axis, and serves to accommodate a femoral head screw. The center axis of the first bore forms an angle with the longitudinal axis that ranges from 110° to 150°. A second bore is located between the first bore and the proximal end and extends through the proximal end and transversely intersects the longitudinal axis, and serves to accommodate a hip pin. The second bore is at least partially shaped as an oblong hole or slot with a width B and a length L>B, and the length L of the oblong hole extends in the direction of the longitudinal axis.
Patent AU-613024-B2 (AU)
Title: Process for the production of 2,3-dimethylbutene-1 from propene
Inventor: KENT ALEXANDER GEORGE
IPC: C07C5/25
Filed: 1988-04-20
Granted: 1991-07-25
Abstract: 2.3-Dimethylbutene-1 (2,3-DMB1) is produced from propene by a process comprising the steps of:   (A) converting propene in one or more stages to a product comprising 2,3-dimethylbutene-2 (2,3-DMB-2) under conditions whereby the proportion of 2,3-DMB-2 in the product is maximised,   (B) separating 2,3-DMB-2 from the product of step (A), and (C) contacting the 2,3-DMB-2 separated in step (B) with a catalyst active for the isomerisation of 2,3-DMB-2 to 2,3-DMB-1 under conditions whereby 2,3-DMB-2 is isomerised to 2,3-DMB-1. e
Patent AU-597171-B2 (AU)
Title: Treatment of gas streams
Inventor: WATSON RICHARD WILLIAM
IPC: C01B17/04
Filed: 1988-05-06
Granted: 1990-05-24
Abstract: A first hydrogen sulphide containing waste gas stream from an oil refinery is combusted in a first combustion chamber 16 using pure oxygen to support combustion. The combustion products are cooled in heat exchanger 20, and a part of the combustion products are recycled to the chamber 16 to moderate the temperature therein. The remainder of the combustion products are mixed with a second hydrogen sulphide containing waste gas stream of different composition from the first stream. A proportion of the hydrogen sulphide content of the mixed stream is combusted in combustion chamber 28 again using pure oxygen to support the combustion. The resulting sulphur dioxide reacts with residual hydrogen sulphide to form sulphur vapour.
Patent AU-650972-B2 (AU)
Title: Aromatic compounds derived from imine, their preparation and their use in human and veterinary medicine and in cosmetics
Inventor: ROCHER JEAN-PHILIPPE
IPC: C07H15/00
Filed: 1992-05-15
Granted: 1994-07-07
Abstract: Diaromatic compounds corresponding to the following general formula: <IMAGE>  in which:   R1 is H, OH, -CH3, -CH2OH, -COR7, -CH(OH)CH3, -CH2OCOR8, and the like,     R7 is H, OH, -OR10, N(r'r"), lower alkyl, and the like,   R8 is linear or branched alkyl, or a sugar residue,   R9 is OH, lower alkyl or N(r'r"),   R10 being alkyl or alkenyl, r' and r" are H, a lower alkyl, an aryl, aralkyl, and the like, or r' and r" form a heterocycle,     R2 and R6 are H, OH, lower alkyl, and the like,   R3 and R5 are  alpha , alpha '-disubstituted alkyl or cycloalkyl,   R4 is H, OH, alkoxy, or  alpha , alpha '-disubstituted alkyl, R3 and R4 or R4 and R5, taken together, can form a ring containing 5 or 6 C,   Z is O, S, -CH=CR11- or -N=CR12-,     R11 being H, OH or lower alkyl,   R12 being H or lower alkyl,     X is (i) -CR13=N-, (ii) -N=CR13-, <IMAGE> <IMAGE>     R13 being R16, OR16, -SR16 or NR16R17   R16 and R17 being H, a lower alkyl, a fluoroalkyl and the like,   R14 being alkyl   R15 being lower alkyl or lower fluoroalkyl,   with the exception of the compounds of the formula (I) when R3 and R5 are identical and X represent the -CR13=N- radical, R13 being H, and the salts of the said compounds of formula (I).
Patent AU-605864-B2 (AU)
Title: Human tissue factor related dna segments, polypeptides and antibodies
Inventor: MORRISSEY JAMES H
IPC: A61P7/02
Filed: 1988-03-29
Granted: 1991-01-24
Abstract: Uses of monoclonal antibodies that bind to DNA segments defining a structural gene coding for a human tissue factor heavy chain protein are disclosed. Also disclosed are uses of monoclonal antibodies that bind to precursor forms and analogues of those proteins.
Patent AU-762624-B2 (AU)
Title: Bupropion to treat viral diseases
Inventor: REINDLER CHRISTOPHER WILLIAM
IPC: A61K31/137
Filed: 1999-12-07
Granted: 2003-07-03
Abstract: Disclosed is a method and composition for the treatment and prevention of a viral infection in a human or animal subject by administering bupropion or a physiologically acceptable salt, solvate or enantiomer thereof. Preferably, the virus is a virus of the Herpes family or condition caused thereby, particularly HSV1 or HSV2.
Patent AU-780602-B2 (AU)
Title: Preservation of sensitive biological material
Inventor: BRONSHTEIN VICTOR
IPC: C12N5/071
Filed: 2000-11-22
Granted: 2005-04-07
Abstract: This invention relates to formulations and methods for preserving sensitive biologicals, viruses, bacteria and eukaryotic cells by drying. More particularly, the invention relates to preservation mixtures comprising viruses or cells and protectants, including methylated monosaccharides, wherein the mixtures are adapted to stabilize these samples during dehydration and subsequent storage at ambient and higher temperatures.
Patent AU-699575-B2 (AU)
Title: Cellular material detection apparatus and method
Inventor: SQUIRRELL DAVID JAMES
IPC: C12M1/34
Filed: 1995-03-13
Granted: 1998-12-10
Abstract: A method and apparatus for monitoring a gaseous environment for the presence of cellular material capable of providing a measure of presence and/or numbers of cellular microorganisms, such as bacterial cells, in a large volume of air such as in a warehouse or production facility or in an open air location where bacterial presence is suspected. The method and apparatus are particularly suited for determining the likelihood of pathogenic material being present in an environment by batch or on-line measurement of cell numbers. On-line measurement provides continuous monitoring of an environment for presence of pathogens. The device includes a continuous flow luminometer preferably fed by a cyclone or high velocity virtual impactor and luminescence reagents which detect the amount of ATP or adenylate kinase present in a sample of air.
Patent AU-773840-B2 (AU)
Title: Process for production of optically active pyrroloazepine derivatives
Inventor: MIZUNO AKIRA
IPC: C07D487/04
Filed: 2000-12-14
Granted: 2004-06-10
Abstract: It is provided a method for preparing the pyrroloazepine derivatives, especially in optically active form useful as drugs, by low-priced and simple method and in industrial applicable scale, represented by the following formula (I): <CHEM> wherein Z represents optionally substituted phenyl group, which comprises;   a process for the asymmetric reduction of ketone compound with metal hydride compound and alcohol compound in the presence of optically active cobalt complex catalyst, and a process for the purification of the resulting compound.
Patent AU-755799-B2 (AU)
Title: Novel beta-lactamase and DD-peptidase inhibitors
Inventor: BESTERMAN JEFFREY M
IPC: A61P31/04
Filed: 1998-12-23
Granted: 2002-12-19
Abstract: The invention provides novel beta-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic beta-lactamase inhibitors presently available, and which do not possess beta-lactam pharmacophore. These new inhibitors are fully synthetic, allowing ready access to a wide variety of structurally related analogs. Certain embodiments of these new inhibitors also bind bacterial DD-peptidases, thus potentially acting both as beta-lactamase inhibitors and as antibiotics.
Patent AU-657787-B2 (AU)
Title: Novel bioprocess for preparing 7-ADCA
Inventor: CONDER MICHAEL J
IPC: C12N15/00
Filed: 1992-09-11
Granted: 1995-03-23
Abstract: (A) A novel process for preparing 7-aminodesacetoxy cephalsporanic acid (7-ADCA) is claimed comprising (a) maintaining in a culture medium capable of sustaining its growth, a strain of Penicillium chrysogenum (PC) which produces isopenicillin N (IPN) and adding to the culture medium an adipate feedstock comprising adipic acid or one or more of its salts and esters which are capable of being assimilated and utilised by the strain of PC to produce adipoyl-6-amino penicillanic acid (adipoyl-6-APA), where the strain of PC has been transformed by DNA encoding the activity of the expandase enzyme capable of accepting the adipoyl-6-APA as a substrate so that as a result of its expression, the adipoyl-6-APA produced by the strain is in situ ring expanded to form adipoyl-7-ADCA and (b) contacting the adipoyl-7-ADCA with an adipoyl cyclase whereby the adipoyl side chain is removed and 7-ADCA is formed which is then isolated. Also claimed are: (B) a recombinant DNA expression vector comprising DNA encoding the activity of the expandase enzyme derived from Streptomyces clavuligerus (S.C) ATCC 27064 and a promoter which drives expression of the expandase activity-encoding DNA comprising the promoter of the PC IPN synthetic (IPNS) gene; (C) a PC host cell transformed with a recombinant DNA expression vector as in (B).
Patent AU-566789-B2 (AU)
Title: Accelerating solid particles in a carrier gas
Inventor: SCHLEIMER FRANCOIS
IPC: C21C5/46
Filed: 1984-03-09
Granted: 1987-10-29
Abstract: A method and apparatus for accelerating solid particles entrained in a carrier gas so as to maximize the velocity of the particles at the output end of a duct is presented. This maximized or optimal acceleration is achieved by varying the cross section of the duct over at least the last 5 meters upstream from the opening thereof. Preferrably, the cross section of the duct should continuously increase i.e. diverge, towards the opening. This diverging cross section is preferrably in accordance with a nonlinear function of the length.
Patent AU-705967-B2 (AU)
Title: Improved lotion composition for treating tissue paper
Inventor: KLOFTA THOMAS JAMES
IPC: A61K8/36
Filed: 1995-05-23
Granted: 1999-06-03
Abstract: A lotion composition for imparting a soft, lubricious, lotion-like feel when applied to tissue paper in amounts as low as from about 5 to about 15% by weight, and tissue paper treated with such lotion compositions are disclosed. The lotion composition comprises plastic or fluid emollient such as petrolatum, or a mixture of petrolatum with alkyl ethoxylate emollient, an immobilizing agent such as a fatty alcohol or fatty acid to immobilize the emollient on the surface of the tissue paper web and optionally a hydrophilic surfactant to improve wettability when applied to toilet tissue. Because less lotion is required to impart the desired soft, lotion-like feel benefits, detrimental effects on the tensile strength and caliper of the lotioned paper are minimized or avoided.
Patent AU-777562-B2 (AU)
Title: Internal vortex mechanism for inhaler device
Inventor: GENOSAR AMIR
IPC: A61M11/02
Filed: 2000-11-01
Granted: 2004-10-21
Abstract: A metered dose inhaler for use with a pressurized aerosol canister includes a housing defining a conduit with a mouthpiece, and an actuator with a nozzle discharge orifice arranged to discharge aerosol into the conduit. Vortex generators positioned within the wall of the conduit and in fluid communication with air inlets for receiving ambient outside air, provide the inner wall of the conduit with a circumferential-swirling turbulent boundary layer flow to minimize impaction of medication on the inner surfaces of the conduit.
Patent AU-758772-B2 (AU)
Title: Towing vehicle for towing persons which move on rollers or gliding bodies
Inventor: TIMM ANTONIO
IPC: B62D51/06
Filed: 2000-01-22
Granted: 2003-03-27
Abstract: The invention relates to a towing vehicle which moves on rollers or sliding bodies, for towing persons. The towing vehicle is provided with a motor drive which drives a driving wheel (1) that is mounted in a chassis (2). The towing vehicle can be controlled by the person through a steering column (8). According to the invention, the chassis (2) also has a supporting wheel (4) which is located behind the driving wheel (1). The steering column (8) is fixed to the chassis by a pitch joint (7) running parallel to the axis of rotation of the driving wheel (1), said pitch joint being situated in front of the axis of the driving wheel (1). The invention enables the towing vehicle to be used especially for towing inline skaters at high speeds.
Patent AU-653279-B2 (AU)
Title: Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
Inventor: HLASTA DENNIS JOHN
IPC: A61P43/00
Filed: 1992-11-27
Granted: 1994-09-22
Abstract: 4-R<4>-R<5>-2-Saccharinylmethyl heterocyclic carboxylates, having the formula: <CHEM>  wherein: Het is a 5- or 6-membered monocyclic heterocycle or a 9- or 10-membered bicyclic heterocycle containing from 1 to 2 heteroatoms selected from oxygen, nitrogen and sulfur or said heterocycles substituted by from one to three, the same or different, members of the group consisting of lower-alkyl, perfluorolower-alkyl, lower-alkoxy, oxo, phenyl, halogen, and -O-(C2-C10 alkylene)-N=B where N=B is dilower-alkylamino, 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 1-piperazinyl, or 4-lower-alkyl-1-piperazinyl; R<4> is hydrogen, halogen , lower-alkyl, perfluorolower-alkyl, perchlorolower-alkyl, lower-alkenyl, lower-alkynyl, cyano, carboxamido, amino, lower-alkylamino, dilower-alkylamino, lower-alkoxy, benzyloxy, lower-alkoxycarbonyl, hydroxy or phenyl; and R<5> is hydrogen or from one to two substituents in any of the 5-, 6- or 7-positions. The compounds of the present invention inhibit the activity of serine proteases, specifically human leukocyte elastase and the chymotrypsin-like enzymes, and are thus useful in the treatment of degenerative disease conditions such as emohysema, rheumatoid arthritis, pancreatitis, cystic fibrosis, chronic bronchitis, adult respiratory distress syndrome, inflammatory bowel disease, psoriasis, bullous pemphigoid and alpha-1-antitrypsin deficiency.
Patent AU-658961-B2 (AU)
Title: Apparatus and method for mounting items at an inaccessible wall surface
Inventor: BERENTER ALLEN
IPC: F16L3/04
Filed: 1992-11-13
Granted: 1995-05-04
Abstract: A through-wall sleeve assembly (10) includes an elongate sleeve (15) having an axial passage, open ends and a radially constrictable frustoconical flange (16) at one of the ends. The sleeve (15) is inserted through a bore in a wall, with the flange (16) at the leading end of the sleeve (15) so that the flange (16) is constricted by the wall or by an outer tube inserted in the bore. The flange (16) returns to an expanded, relaxed condition when it projects beyond a remote surface of the wall and forms a seal (20) with the remote surface when the sleeve (15) is drawn back. An item such as a nozzle (36) hook or eye having external threads (34) is inserted in the axial passage and fixed relative to the sleeve (15).
Patent AU-685990-B2 (AU)
Title: Fuel composition
Inventor: GAMBINI PAOLA
IPC: C10L1/16
Filed: 1995-09-19
Granted: 1998-01-29
Abstract: Fuel composition for internal combustion engines which comprises a larger portion of fuel and a smaller quantity of a composition of hydrocarbon oligomers almost totally saturated, characterized in that the above composition of almost totally saturated hydrocarbon oligomers:   1) is obtained by the oligomerization and subsequent hydrogenation of a hydrocarbon composition comprising basically C13-C18, preferably C15-C16, internal oligomers, in a quantity of more than 90% by weight, 2) is basically without any possible hydrocarbons having a number of carbon atoms equal to or less than 13, 3) has a viscosity at 100 DEG C of betweem 5.0 and 12.0 cSt, particularly from 7.3 to 8.4 cSt.
Patent AU-702103-B2 (AU)
Title: Repulpable pressure-sensitive adhesive constructions having multiple layers
Inventor: SCHOLZ WILLIAM F
IPC: C09J7/38
Filed: 1995-09-15
Granted: 1999-02-11
Abstract: A pressure-sensitive adhesive construction repulpable in paper recycling operations, comprising a facestock which is repulpable; a dispersible pressure-sensitive adhesive comprising tacky emulsion polymers dispersible in water; and a nondispersible pressure-sensitive adhesive comprising tacky emulsion polymers not dispersible in water, wherein, on the facestock, the dispersible pressure-sensitive adhesive is closer to the facestock than the nondispersible pressure-sensitive adhesive, thereby improving both adhesive performance and recyclability.
Patent AU-610413-B2 (AU)
Title: 19-fluoro-or cyano-21-hydroxy-progesterone derivatives useful as 19-hydroxylase inhibitors
Inventor: HOLBERT GENE W
IPC: C07J5/00
Filed: 1989-06-28
Granted: 1991-05-16
Abstract: 19-Fluoro- and cyano- substituted 21-hydroxyprogesterone derivatives and related compounds which are active as 19-hydroxylase inhibitors and useful as antihypertensive agents are described herein. The compounds are prepared using appropriate synthetic pathways which will vary according to the nature of the specific 19-substituted progesterone or related compound desired.